Cargando…
Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy
BACKGROUND: Prior research has demonstrated that medication persistence (continued acquisition of therapy over time) is far from optimal among patients with glaucoma. The purpose of the present study was to evaluate persistence with prostaglandin analogs among glaucoma patients in the first therapy...
Autores principales: | Reardon, Gregory, Schwartz, Gail F, Kotak, Sameer |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2843652/ https://www.ncbi.nlm.nih.gov/pubmed/20196848 http://dx.doi.org/10.1186/1471-2415-10-5 |
Ejemplares similares
-
Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review
por: Reardon, Gregory, et al.
Publicado: (2011) -
Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: Retrospective analysis of three medical/pharmacy claims databases
por: Schwartz, Gail F, et al.
Publicado: (2011) -
Ocular hypotensive effect, preservation of visual fields, and safety of adding dorzolamide to prostaglandin therapy for twelve months
por: Inoue, Kenji, et al.
Publicado: (2011) -
Episcleral Venous Pressure and the Ocular Hypotensive Effects of Topical and Intracameral Prostaglandin Analogs
por: Lee, Susan S., et al.
Publicado: (2019) -
Patient adherence and persistence with topical ocular hypotensive therapy in real-world practice: a comparison of bimatoprost 0.01% and travoprost Z 0.004% ophthalmic solutions
por: Campbell, Joanna H, et al.
Publicado: (2014)